D-0395-2021 Class I Terminated
FDA drug recall D-0395-2021 was initiated by Acella Pharmaceuticals, LLC on Apr 29, 2021 and is designated Class I. Reason for recall: Subpotent Drug The recall status is terminated (terminated Mar 13, 2024). Affected quantity: a) 66,155 bottles; b) 26,212 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 2, 2021
- Initiation Date
- Apr 29, 2021
- Termination Date
- Mar 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 66,155 bottles; b) 26,212 bottles
Product description
NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg), packaged in a) 100-count bottles (NDC 42192-327-01) and b) 7-count bottles (NDC 42192-327-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide within the United States including Puerto Rico
Code information
Lots: a) M327D20-1, M327D20-3 Exp. 03/31/2022, M327H19-3A Exp. 07/31/2021, M327L19-1 Exp. 04/30/2021; b) M327D20-1 Exp. 03/31/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0395-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026